Vaccine-induced thrombotic thrombocytopenia, renal vein thrombosis, pulmonary embolism
The Medicines and Healthcare products Regulatory Agency (MHRA) of the UK has approved the use of three vaccines to combat COVID-19 (SARS-CoV-2). There have been rare reports of thrombosis after vaccination with the AstraZeneca vaccine. We present three cases of vaccine-induced thrombotic thrombocytopenia (VITT) in one UK district general hospital following administration of this vaccine. Two of the patients had asymptomatic pulmonary emboli, while the other is the first known case of both renal vein thrombosis and pulmonary embolism.
HTML downloads: 218
PDF downloads: 549
Issue: 2021: Vol 8 No 6 (view)